Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

NCT02405520 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Condylomata Acuminata

Interventions

BIOLOGICAL: low dosage HPV Vaccine
BIOLOGICAL: medium dosage HPV Vaccine
BIOLOGICAL: high dosage HPV Vaccine
BIOLOGICAL: Aluminium Adjuvant

Sponsor

Jun Zhang

Collaborators

[object Object]
[object Object]